Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-49K24.6 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | PCDHA3 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | ZNF491 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | SATL1 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | NFS1 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | EPGN | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
mRNA | ZNF664 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | RAB9B | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | SV2A | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | FBXO15 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |